Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 415
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00080912 | Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases | ||
| NCT05576831 | STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision | ||
| NCT03108144 | Personalized Alerts and Care Pathways to Prompt Prevention Interventions for Alcohol and Tobacco Users in Primary Care | ||
| NCT06809322 | Vorasidenib Maintenance for IDH Mutant Astrocytoma | ||
| NCT03795493 | Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer | ||
| NCT01805778 | Preventing Cardiac Sequelae in Pediatric Cancer Survivors | ||
| NCT01830621 | BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma | ||
| NCT00238316 | Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density | ||
| NCT05754840 | CANnabinoids in Pediatric ONCology | ||
| NCT02537418 | Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens | ||
| NCT05714891 | Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer | ||
| NCT00352079 | BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer | ||
| NCT00443976 | Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma | ||
| NCT01068587 | MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy | ||
| NCT01354171 | Active Surveillance Magnetic Resonance Imaging Study | ||
| NCT03585634 | The Dads in Gear Program: An Innovative Men-centered Approach to Smoking Cessation | ||
| NCT03450018 | A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX | ||
| NCT02637024 | Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation | ||
| NCT06880523 | STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma | ||
| NCT00255788 | Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer | ||
| NCT01145989 | A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT02343718 | Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours | ||
| NCT05640999 | Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER | ||
| NCT04650581 | Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor | ||
| NCT00004251 | Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer | ||
| NCT03831178 | Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting | ||
| NCT02511522 | Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases | ||
| NCT00754845 | Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy | ||
| NCT00188708 | Effect of Casodex on Tumour Hypoxia - Prostate Cancer | ||
| NCT04918186 | Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer | ||
| NCT00201890 | Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY" | ||
| NCT04031677 | Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | ||
| NCT06863129 | Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial | ||
| NCT00003653 | Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer | ||
| NCT02784171 | Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma | ||
| NCT00640471 | Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer | ||
| NCT04543851 | CARA Treatment Pilot Study for Breast Positioning | ||
| NCT03568422 | CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer | ||
| NCT00003372 | Topotecan in Treating Patients With Recurrent Brain Tumors | ||
| NCT03938987 | Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) | ||
| NCT05997901 | Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study | ||
| NCT04079764 | Surveillance of Complex Renal Cysts - the SOCRATIC Pilot Study | ||
| NCT04663997 | 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer | ||
| NCT01913093 | N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors | ||
| NCT03860883 | Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma | ||
| NCT01916187 | Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma | ||
| NCT03550391 | Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases | ||
| NCT00017004 | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | ||
| NCT05236855 | Spectroscopy and Artificial Intelligence to Disrupt the Status Quo in Cervical Cancer Screening | ||
| NCT01389739 | Intervention to Improve Continuity of Care in Lung Cancer Patients |
